
|Videos|March 23, 2023
Use of Spesolimab in the Treatment of GPP
Author(s)Raj Chovatiya, MD, PhD, MSCI
Dr Raj Chovatiya discusses a recently approved therapeutic agent, spesolimab, as a valuable addition to the GPP treatment landscape.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Social Media Mythbusters: The Summer Skin Care "Shutdown"
2
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
3
ED Treatment Gaps Persist for Pediatric Atopic Dermatitis
4
Breakout Bulletin: July 13-July 17
5














